A carregar...
HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
BACKGROUND: Chemotherapy resistance presents a difficult challenge in treating epithelial ovarian cancer patients, particularly when tumors exhibit resistance to multiple chemotherapeutic agents. A few studies have shown that elevated serum levels of the ovarian cancer biomarker HE4 correlate with t...
Na minha lista:
| Publicado no: | J Ovarian Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869286/ https://ncbi.nlm.nih.gov/pubmed/27184254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-016-0240-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|